CBR4 (C-term), 178-205 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CBR4 (C-term), 178-205 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CBR4 (C-term), 178-205 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This CBR4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 178-205 amino acids from the C-terminal region of human CBR4. The heteroteramer with HSD17B8 has NADH-dependent 3-ketoacyl-acyl carrier protein reductase activity. May play a role in biosynthesis of fatty acids in mitochondria. The homotetramer may act as NADPH-dependent quinone reductase. Has broad substrate specificity and reduces 9,10-phenanthrenequinone, 1,4-benzoquinone and various other o-quinones and p-quinones (in vitro). |
| Immunogen | n/a |
| Other Names | [Carbonyl reductase family member 4; 1---; 3-oxoacyl-[acyl-carrier-protein] reductase; 111-; Quinone reductase CBR4; CBR4] |
| Gene, Accession # | [CBR4], Gene ID: 84869, NCBI: NP_116172.2, UniProt: Q8N4T8 |
| Catalog # | MBS9200844 |
| Price | $165, $370 |
| Order / More Info | CBR4 (C-term), 178-205 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Chen, Z., et al. FASEB J. 23(11):3682-3691(2009) Persson, B., et al. Chem. Biol. Interact. 178 (1-3), 94-98 (2009) : Endo, S., et al. Biochem. Biophys. Res. Commun. 377(4):1326-1330(2008) Lamesch, P., et al. Genomics 89(3):307-315(2007) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies